
XFOR
USDX4 Pharmaceuticals Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$4.000
Максимум
$4.120
Минимум
$3.940
Объем
0.20M
Фундаментальные показатели компании
Рыночная капитализация
314.5M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
4.09M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals with a Buy and raises the price target from $3.5 to $5.
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the closing of its
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its
Связанные акции
AGCO
AGCO Corporation
FYBR
Frontier Communications Parent Inc.
PTPI
Petros Pharmaceuticals Inc.
NBB
Nuveen Taxable Municipal Income Fund Common Shares of Beneficial Interest
ALTO
Alto Ingredients Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.